Skip to Content

Tag: Financial Results


Also Noted

Option Care expects double-digit growth in Q3

October 20, 2021HME News Staff

BANNOCKBURN, Ill. – Option Care Health has released preliminary financial results for the third quarter ending Sept. 30, including net revenue of about $888 million to $893 million, representing 14% growth compared to the same period last year. The company expects net income of about $33 million to $36 million. Option Care also expects to report adjusted EBITDA of about $76 million to $79 million, representing 28% to 34% growth; cash flow from operations of about $50 million to $52 million;...

Financial Results, Home Infusion, Option Care Health


Read Full Articlered right arrow icon

Providers

Quipt has opportunity to ‘scale aggressively,’ it says

August 24, 2021HME News Staff

CINCINNATI – Quipt Home Medical has reported revenue of $26.2 million for the third quarter of 2021 compared to $18.6 million for the same period last year, a 41% increase.  The company reported net income of $6.3 million compared to a net loss of $2.5 million.  “We continue to produce exceptional results, highlighted by our robust organic growth, driven by the strong execution displayed across the organization, comprised of over 600 dedicated team members,” said...

Financial Results, Quipt Home Medical


Read Full Articlered right arrow icon

Vendors

Inogen sees recovery, but supply chain constraints pile up

August 5, 2021HME News Staff

GOLETA, Calif. – Inogen reported total revenue of $101.6 million for the second quarter of 2021, a 41.7% increase compared to the same period in 2020, primarily due to strong consumer demand, improved average selling prices in all channels and reduced COVID-19 pandemic-related impacts. The company reported domestic direct-to-consumer revenue of $40.9 million, a 35.6% increase. Rental revenue was $11.3 million, an 85.2% increase. “We saw strong revenue growth of 41.7% as compared...

Financial Results, Inogen


Read Full Articlered right arrow icon

Matt Monaghan

Vendors

Invacare sees ‘strong growth’ for North America

August 5, 2021HME News Staff

ELYRIA, Ohio – Invacare reported net sales increased 15.1% to $225.9 million in the second quarter of 2021 compared to the same period in 2020. Net sales for the North America business unit increased 11.2% to $96.2 million year over year, with strong growth in mobility and seating, and respiratory products. “We achieved high single-digit constant currency net sales growth, with increases in all product categories,” said Matt Monaghan, chairman, president and CEO. “Importantly,...

Financial Results, Invacare


Read Full Articlered right arrow icon

Steve Griggs

Providers

Adapt Health reports increases

August 5, 2021HME News Staff

PLYMOUTH MEETING, Mass. – Adapt Health reported net revenue of $617 million for the second quarter of 2021, an increase of 166% over the second quarter in 2020.  Adjusted EBITDA was $147.4 million, a 246% increase; and adjusted EBITDA less patient equipment capex was $98.9 million, a 223% increase.  Organic growth for the quarter was 10.1%.  “Our business continues to grow organically as well as through strategic acquisitions in key markets, which complement our...

AdaptHealth, Financial Results


Read Full Articlered right arrow icon

Vendors

Philips sees sales fall for Sleep & Respiratory Care

July 26, 2021HME News Staff

AMSTERDAM – Philips reported a 16% decline in sales for its Connected Care business, which includes Sleep and Respiratory Care, for the second quarter of 2021 compared to the same period last year, in the wake of a massive recall of certain CPAP devices and ventilators.  Mid-single-digit growth in Hospital Patient Monitoring was more than offset by a double-digit decline in Sleep & Respiratory Care, the company says.  “We have mobilized the necessary resources across the...

Financial Results, Philips, Recall


Read Full Articlered right arrow icon

Dan Starck

Providers

Apria increases full year guidance

May 17, 2021HME News Staff

INDIANAPOLIS – Apria reported net revenue of $275.3 million for the first quarter of 2021, a 2% increase compared to the same period last year.  It reported a net income of $4.5 million, a 29% decrease.  “We delivered strong first quarter 2021 results ahead of our expectations on all three of our key metrics and we built on momentum from 2020 establishing a solid foundation for future growth,” said Dan Starck, CEO. “The country experienced a significant surge...

Apria, COVID-19, Financial Results


Read Full Articlered right arrow icon

Casey Hoyt

Specialty Providers

Viemed sees patient uploads rebound in March

May 4, 2021HME News Staff

LAFAYETTE, La. – Viemed Healthcare reported net revenues for its core business were $25.5 million for the first quarter ended March 31, 2021, a 12% increase compared to the same quarter last year.  Total revenues were $28.4 million, including $2.9 million for contract tracing services and product sales related to the COVID-19 pandemic.  “The first quarter will very likely be the quarter where things began to reopen from the COVID-19 pandemic and I am once again...

COVID-19, Financial Results, Respiratory Therapy, Viemed Healthcare


Read Full Articlered right arrow icon

Providers

Protech Home Medical reports ‘robust’ financial results

March 2, 2021HME News Staff

CINCINNATI – Protech Home Medical reported revenue of $22.8 million for the first quarter of fiscal year 2021, a 32% increase compared to the same period in 2020.  Adjusted EBITDA was $5.1 million vs. $3.3 million, a 53% increase.  “The momentum across the business continues to be robust as evidenced by our first quarter financial and operating results, and I am pleased to saw that we are seeing similar strong trends into our second quarter,” said CEO and Chairman...

Financial Results, Protech Home Medical, Respiratory Therapy


Read Full Articlered right arrow icon

Oventus reports significant growth

Also Noted

Oventus reports significant growth

February 22, 2021HME News Staff

BRISBANE, Australia – Oventus Medical has booked revenues of $550,232 for the six-month period ended Dec. 31, a 192% increase over the prior period. The company credits growth driven by lab-in-lab sites that remained operational during the pandemic, continuing to scan patients; an expansion of the telehealth extension of the lab-in-lab program; and an increase in direct sales to dentists who delivered treatments in their own practices, as well as through lab-in-lab programs. “We...

Financial Results, Obstructive Sleep Apnea, Oventus Medical, Telehealth


Read Full Articlered right arrow icon